What is Lee's Pharmaceutical Holdings Price-to-Operating-Cash-Flow?
As of today (2024-12-14), Lee's Pharmaceutical Holdings's share price is HK$1.38.
Lee's Pharmaceutical Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.22. Hence, Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow Ratio for today is 6.24.
The historical rank and industry rank for Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:00950'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.51 Med: 9.59 Max: 38.07
Current: 6.24
During the past 13 years, Lee's Pharmaceutical Holdings's highest Price-to-Operating-Cash-Flow Ratio was 38.07. The lowest was 2.51. And the median was 9.59.
Lee's Pharmaceutical Holdings's Cash Flow from Operations per share for the
six
months ended in Jun. 2024 was HK$0.10.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.22.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Lee's Pharmaceutical Holdings was 85.70% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -20.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -16.60% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -2.10% per year.
During the past 13 years, Lee's Pharmaceutical Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 400.00% per year. The lowest was -20.50% per year. And the median was 25.20% per year.
Lee's Pharmaceutical Holdings Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lee's Pharmaceutical Holdings Price-to-Operating-Cash-Flow Chart
|
Lee's Pharmaceutical Holdings Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
6.54 |
12.72 |
9.30 |
3.38 |
8.18 |
|
Lee's Pharmaceutical Holdings Semi-Annual Data
|
|
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
Jun24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
3.38 |
- |
8.18 |
- |
Competitive Comparison of Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow falls into.
Lee's Pharmaceutical Holdings Price-to-Operating-Cash-Flow Calculation
Lee's Pharmaceutical Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 1.38 | / | 0.221 |
| = | 6.24 |
Lee's Pharmaceutical Holdings's Share Price of today is HK$1.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lee's Pharmaceutical Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Lee's Pharmaceutical Holdings Business Description
Traded in Other Exchanges
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
Executives
Lee's Pharmaceutical Holdings Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00950 has been successfully added to your